Drug Shortage Report for CODEINE PHOSPHATE INJECTION USP
| Report ID | 158706 |
| Drug Identification Number | 00544884 |
| Brand name | CODEINE PHOSPHATE INJECTION USP |
| Common or Proper name | CODEINE PHOSPHATE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | DORMANT |
| Active Ingredient(s) | CODEINE PHOSPHATE |
| Strength(s) | 30MG |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
| Packaging size | 1ML 10LIAM |
| ATC code | R05DA |
| ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-04-12 |
| Estimated end date | Unknown |
| Actual end date | 2022-04-20 |
| Shortage status | Resolved |
| Updated date | 2022-04-20 |
| Company comments | Discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-04-20 | French | Compare |
| v3 | 2022-04-20 | English | Compare |
| v2 | 2022-04-13 | French | Compare |
| v1 | 2022-04-13 | English | Compare |
Showing 1 to 4 of 4